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Abstract.  The Cyberknife system (Accuray Inc., Sunnyvale, CA) enables radiotherapy using 14 
stereotactic ablative body radiotherapy (SABR) with a large number of non-coplanar beam 15 
orientations.  Recently, a multileaf collimator has also been available to allow flexibility in 16 
field shaping.  This work aims to evaluate the quality of treatment plans obtainable with the 17 
multileaf collimator.  Specifically, the aim is to find a subset of beam orientations from a 18 
predetermined set of candidate directions, such that the treatment quality is maintained but the 19 
treatment time is reduced.  An evolutionary algorithm is used to successively refine a 20 
randomly selected starting set of beam orientations.  By using an efficient computational 21 
framework, clinically useful solutions can be found in several hours.  It is found that 15 beam 22 
orientations are able to provide treatment quality which approaches that of the candidate beam 23 
set of 110 beam orientations, but with approximately half of the estimated treatment time.  24 
Choice of an efficient subset of beam orientations offers the possibility to improve the patient 25 
experience and maximise the number of patients treated. 26 
 27 
Highlights: 28 
 A fast optimisation framework is used to create IMRT SABR plans for Cyberknife. 29 
 The value of the Cyberknife multileaf collimator is investigated. 30 
 A beam selection algorithm is used to determine a subset of beam orientations. 31 
  Fifteen selected beams are sufficient to create high-quality treatment plans. 32 
 Treatment time is minimised using this approach. 33 
 34 
Keywords: Cyberknife, multileaf collimator, beam-orientation selection, IMRT, inverse 35 
planning. 36 
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Abbreviations 38 
BOS  Beam orientation selection 39 
CT  Computed tomography 40 
IMRT  Intensity-modulated radiotherapy 41 
L-BFGS  Limited-memory Broyden-Fletcher-Goldfarb-Shanno 42 
MLC  Multileaf collimator 43 
PTV  Planning target volume 44 
SABR  Stereotactic ablative body radiotherapy 45 
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1.  Introduction 46 
The Cyberknife system (Accuray Inc., Sunnyvale, CA) includes a multileaf collimator 47 
(MLC), which allows maximal flexibility in field shaping and fewer monitor units in stereotactic 48 
radiosurgery than with a cone collimator [1, 2]. The MLC consists of 26 leaf pairs, each of width 49 
3.85mm, giving a maximum field size of 115 mm × 100 mm at a nominal source-axis distance of 800 50 
mm. 51 
The standard beam set for a Cyberknife stereotactic ablative body radiotherapy (SABR) 52 
treatment uses 110 beams, referred to as nodes.  These are typically non-isocentric and non-coplanar, 53 
and are chosen so as to provide a collision-free path for the delivery robot around the patient [1].  54 
However, such a large number of beams is unlikely to be necessary for many, if not all, treatment 55 
sites, and may lead to an excessive treatment delivery time without much benefit [3].  This work 56 
therefore aims to determine an optimal subset of beams for each patient, such that the treatment 57 
quality approaches that of the full node set.  This is accomplished firstly by examining predetermined 58 
beam subsets defined by the manufacturer, and secondly by applying a beam selection technique. 59 
A number of approaches have previously been used for beam orientation selection in 60 
radiotherapy.  As well as the implementation of methods for conformal radiotherapy [4], the more 61 
complex problem of determining beam orientations and fluence maps for intensity-modulated 62 
radiotherapy (IMRT) has been approached by beam’s eye view score methods [5, 6], combination of 63 
individually selected beams [7], successive addition of beams to a pool [8-10], angle perturbation [11-64 
13] and cluster analysis [14].  Other methods have also been reported [15-21].  All of these methods 65 
benefit from fast optimisation methods [22, 23] and comparisons of methods have helped to clarify 66 
the benefits of these approaches [24, 25]. 67 
Some of the recent work on trajectory optimisation for arc therapy can also be applied 68 
usefully to the question of beam orientation selection for Cyberknife.  For example, Smyth et al. [26, 69 
27] find the least cost path through a cost function map based on individual beam metrics.  Wild et al. 70 
[28] also use a path connection algorithm to find the shortest path between desirable orientations.  71 
Locke and Bush [29] also use a path search algorithm, but take into account the connectedness of the 72 
areas of the beam’s eye view which are useful for beam delivery. 73 
Several methods have focused specifically on the Cyberknife device.  For example, Kearney 74 
et al. [30] describe a method for producing arc trajectories for Cyberknife.  A subset of optimal beams 75 
is selected from a complete library of beams, and then these beams are joined using a path selection 76 
method, and formed into a continuous arc. 77 
 78 
 79 
 80 
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2.  Methods and materials 81 
2.1.  Patients and treatment plans 82 
Four patient cases were considered in this study, with tumour sites of prostate and base of 83 
seminal vesicles, lung, liver and partial breast.  The prostate case was planned with two distinct 84 
techniques, as described below, leading to a total of five types of treatment plan.  All treatment plans 85 
used a SABR technique, with hypofractionated dose prescriptions of 3-5 fractions (see Table 1). 86 
 87 
Table 1.  Fractionation schemes used in this study. 88 
 89 
CASE TOTAL DOSE (Gy) FRACTIONS PROTOCOL 
Prostate A 36.25 5 RTOG 0938 
Prostate B 38.00 4 Fuller et al. [31, 32] 
Lung 50.00 5 RTOG 0813 
Liver 42.75 3 Vautravers-Dewas et al. [33] 
Partial breast 35.00 5 RTOG 0413 
 90 
 91 
Patient cases were imported into the in-house treatment planning system DynaPlan and dose 92 
was calculated using a standalone dose calculation module supplied by Accuray Inc., so as to 93 
accurately represent dose delivered by the Cyberknife system.  The computational framework 94 
required that appropriate priorities were assigned to the different anatomical structures outlined on the 95 
CT images so that the optimizer would work correctly in the case of overlap (see Figure 1).  Each 96 
voxel in the volume was assigned to one structure only. 97 
 98 
 99 
 100 
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 101 
 102 
Figure 1.  Overlap and priorities.  Planning target volume (PTV) has the highest priority, followed by 103 
critical structures such as rectum and bladder.  Three annular structures, (A1, A2, A3) with width 10 mm then 104 
follow, and the remainder of the body then has the lowest priority. 105 
 106 
 107 
The inverse planning method required the dose, di, at voxel i to be calculated as [28]: 108 
 109 

j
jiji wdd ,           (1) 110 
 111 
where dij was the dose at voxel i due to fluence wj at element j of the intensity matrices (Figure 2).   112 
 113 
 114 
Figure 2.  Dose model. 115 
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Accordingly, the dose-influence matrix dij was determined by calculating dose distributions for fields 116 
of one intensity bixel in size.  This was an approximation as the dose due to a single large field was 117 
not exactly equal to the sum of doses delivered by a sum of individual bixels, but was considered 118 
accurate enough for this study.  In all cases, the fluence bixel size was 2 × MLC leaf width by 5 mm 119 
and the fluence grid approximately covered the beam’s eye view of the PTV with a 5 mm margin.  In 120 
some regions of some of the beams, the fluence grid was greater in extent than the PTV, and in others, 121 
it was less.  This imperfection was not found to have a significant impact on the results.  The 122 
calculation voxel size was 2 × CT pixel width by 2 × CT pixel height × CT slice spacing.  A lower 123 
dose threshold of 1/60000 of the maximum dose of each dij component was used, which in practice 124 
meant that all scattered dose was incorporated into the inverse planning.  The dij matrices covered the 125 
entire patient, so that the components relating to each beam totalled approximately 1 GB in size.  All 126 
dose voxels were used in structures for which optimisation objectives were specified. 127 
Each treatment plan consisted of 110 beam orientations, using an average of two apertures per 128 
beam orientation (node).  Treatment plans were optimized using an objective function, F, summed 129 
over a number of volumes, i, each with individual objective value fi: 130 
 131 

i
ifF ,           (2) 132 
 133 
with fi defined as: 134 
 135 
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 137 
where ai was a structure-specific importance factor.  Both the minimum and maximum terms were 138 
used for targets, while only the maximum term was used for normal tissues.  A number of iterations, 139 
x, of an iterative gradient descent method were then used to reach a solution for the intensity values in 140 
the fluence matrix: 141 
 142 
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 144 
where α was a relaxation parameter.  The direction vector px was in principle given as: 145 
 146 
    xxx wFwFp  12 .         (5) 147 
 148 
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However, the low-memory Broyden-Fletcher-Goldfarb-Shanno (L-BFGS) method was used to avoid 149 
the memory-intensity calculation of the inverse Hessian matrix    12  xwF .  In this scheme, the 150 
direction vectors were obtained by a recursion relation [28]: 151 
 152 
 FFBpp xx  ,1 .         (6) 153 
 154 
Following fluence optimisation, sequencing was carried out using a standard sequencing 155 
method [34], and aperture optimisation was then carried out, also using a gradient descent method 156 
[28, 35].  This method converted the aperture optimisation problems into a fluence optimisation 157 
problem, so that the same L-BFGS method could be used for aperture optimisation as for fluence 158 
optimisation.  No attempt was made to optimise the numbers of beam directions, apertures or monitor 159 
units (MU) in the final plan. 160 
This method was implemented in a fast multi-threaded planning framework [35].  This 161 
enabled a solution for 110 nodes to be obtained in less than 15 minutes for 40 fluence iterations and 162 
40 iterations of direct aperture optimisation (see Figure 3).  The optimisation itself was implemented 163 
in a high-performance environment, which was a dual Intel Xeon E5-2650 with 128 GB RAM. 164 
 165 
 166 
Figure 3.  Computational system. 167 
 168 
The starting point for comparisons was to use an Accuray-supplied body nodeset with 110 169 
nodes (Figure 4), with a variable number of apertures being specified to the optimizer.  This number 170 
was 2 for the prostate cases, 1 for liver and breast cases, and 3 for the lung case, reflecting the degree 171 
of intricacy required in the solution.  An Accuray-supplied subset of the body nodeset, containing 36 172 
nodes spaced evenly over the same total solid angle, was also used.  This approach was similar to the 173 
standardised bouquet determined by Yuan et al. [36]. 174 
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 175 
 176 
Figure 4.  The body nodeset from which the beams were selected.  (a) transaxial view, (b) coronal view. 177 
 178 
 179 
Beam selection was carried out using a variation of the the evolutionary algorithm of Li et al. 180 
[37], which was also similar to the approach of Hou et al. [38], who used an evolutionary algorithm 181 
for orientation selection and a simulated annealing algorithm for intensity calculation.  The concept of 182 
nesting an intensity calculation inside a beam orientation loop was also used by Rowbottom et al. 183 
[39].  Using this method, 15 beams were selected from the 110-node body nodeset.  Other numbers of 184 
beams were investigated and 15 beams were found to be the practical minimum that allowed for 185 
production of a high-quality dose distribution.  For all orientation-selected cases, five segments per 186 
beam were allowed, except for the liver case, where the relative simplicity of the planning target 187 
volume (PTV) required only three segments per beam to be used.  The method is summarised in 188 
figure 5. 189 
 190 
 191 
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 192 
 193 
Figure 5.  Concepts involved in the evolutionary algorithm used in this work.  The two left-hand lists 194 
represent two node sets in a population, the numbers representing node indices.  The offspring has features of 195 
both of these two individuals, with occasional mutations. 196 
 197 
 198 
A population of 20 plans was used in this work, representing a collection of plans whose 199 
properties were to be successively improved by the evolutionary algorithm.  The beam orientations for 200 
each plan were chosen initially by randomly selecting beam indices from the candidate node set of 201 
110 beams.  This population of individual treatment plans, or individuals, then underwent 20 202 
iterations, or generations.  The generation was defined as the population at a given phase in the 203 
optimisation process.  At each iteration, 20 new individuals were generated from the current 20 204 
individuals, to form the next generation.  In this way, the population was maintained at 20 throughout 205 
the scheme.  The genetic encoding consisted of a list of beam indices used by each individual or 206 
treatment plan.  Note that the fitness function was taken to be the objective function, F, as defined in 207 
equation (2), with lower values representing greater fitness. 208 
To generate a new individual, the fittest tenth of the current population was identified 209 
according to objective function value, and these two individuals were combined.  Each gene, i.e. each 210 
beam index, of the new individual was determined by randomly using a beam index from either of the 211 
parent genes. In this crossover or recombination operation, the probability of using a beam index from 212 
one parent was 0.4 and the probability of using a beam index from the other was 0.6, following 213 
empirical tests.  If the new beam index was identical to a beam index already existing in the new 214 
individual, another attempt was made to generate that particular beam index, and if this also matched 215 
an existing beam index, it was accepted anyway.  This new beam index then underwent mutation, 216 
with a probability of 0.05.  This involved replacing it with another beam index from the set of 217 
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candidate beam indices.  As there was no simple relationship between beam index and beam 218 
orientation, (i.e. beams with adjacent indices did not necessarily have adjacent beam orientations), no 219 
attempt was made to select similar indices or orientations.  Mutation therefore involved a change of 220 
index and orientation that could be considerable. 221 
  The end result of this process was that each randomly selected pair of individuals gave rise 222 
to an offspring.  After 20 of such offspring were generated, they replaced the original individuals, so 223 
that a new generation of 20 plans was produced.  Each of these plans was then optimised using 20 224 
fluence iterations, sequencing, and 20 iterations of direct aperture optimisation.  The whole process 225 
was then repeated for 20 iterations.  In the implementation of Li et al. [37], the optimal plan was taken 226 
as the fittest individual in the final generation.  However, in our implementation, the optimal plan was 227 
taken as the fittest individual to be found in any of the generations.  This was used to provide a similar 228 
effect to elitism, in which the fittest individuals are retained for subsequent generations. 229 
The parameters described above were chosen following empirical tests to determine the 230 
optimum settings.  To demonstrate that the selected values were optimum, the values were perturbed 231 
and the progress of the beam orientation selection (BOS) was evaluated for the prostate B case and the 232 
liver case.  Several different combinations of the crossover proportions and the mutation rate were 233 
evaluated.  Furthermore, to evaluate the statistical accuracy of the evolutionary algorithm, these cases 234 
were recalculated 25 times using different seed values in the random number generator.  The 235 
adequacy of the number of plans and number of generations was also assessed for the prostate B case 236 
by recalculating using 100 plans in 100 generations. 237 
Sometimes the importance factors were adjusted during production of the plans using BOS.  238 
This was mainly to reduce the surface dose when using relatively few beam orientations.  This meant 239 
that the objective values were different for the BOS plan and the reference plan produced from the 240 
body or even path, even for identical dose distributions.  Consequently, where objective values were 241 
compared, the BOS objective value was compared against that for a re-optimised plan using the body 242 
or preset short path but with the same importance factors as used in the BOS plan. 243 
Plans were compared using dose statistics and conformity index, which was defined as the 244 
volume receiving the prescribed dose divided by the volume of the planning target volume.  245 
Treatment times were estimated according to a vendor-supplied algorithm incorporating initial patient 246 
setup, beam-on, MLC reshaping between apertures, robot traversal between nodes and imaging. 247 
 248 
 249 
 250 
 251 
 252 
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3.  Results 253 
The transaxial dose distributions are shown in Figure 6 for the five cases with the 110-node 254 
body node set.  The dose distributions shown are for the dij-based dose distribution output from the 255 
optimiser, without recalculation of the apertures as complete beams.  It can be seen that the dose 256 
distributions are conformal in nature, with appropriate sparing of organs at risk near to the PTV.  A 257 
summary of results over the five patients for the body path, the preset short path and BOS path are 258 
shown in Table 2. 259 
 260 
 261 
 262 
 263 
Figure 6.  Transaxial dose distributions for (a) prostate A, (b) prostate B, (c) lung, (d) liver and (e) partial breast 264 
cases. The dose levels as a percentage of the prescription dose are shown in each case. 265 
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Table 2.  Plan statistics for the five patient cases. 266 
 267 
 BODY 
PATH 
PRESET 
SHORT PATH 
ORIENTATION 
SELECTED PATH 
Number of nodes 110 36 15 
Inverse planning time per run (mins) 10 5 120 
Median apertures 310 158 165 
Median MU per Gy 1575 1881 1499 
Median conformality index 1.03 1.05 1.06 
Median estimated treatment time (mins) 51 37 34 
 268 
 269 
  The orientation selection takes longer for inverse planning than the other techniques due to the 270 
number of plan optimisations required.  The number of apertures approximately follows the number 271 
of nodes in the plan for the body path and the preset short path, although there is a similar number of 272 
apertures for the BOS path as with the preset short path, for rather fewer beams.  The estimated 273 
treatment time follows accordingly.  The monitor units per gray and conformity index are 274 
approximately constant for all three of the types of treatment plan. 275 
The impact of the parameters used in the evolutionary algorithm on the median final objective 276 
value for the BOS result in the prostate B case is shown in Table 3.  Run 1, the standard case, is 277 
shown to be competitive with the other runs using different parameters.  Only run 7 has a median final 278 
objective value which is appreciably lower than that of run 1, but takes many hours to achieve the 279 
result.  Figure 7 shows the objective values for 20 iterations of the BOS scheme for the prostate B 280 
case, corresponding to run 1 of Table 3.  The optimisation rapidly reaches convergence to a fit 281 
population of treatment plans.  The minimum objective value encountered is better than that of the 282 
preset short path and approaching that of the body path.  It can be seen that there is scope to reduce 283 
the number of iterations, as the global solution is found relatively rapidly.  Figure 8 shows the results 284 
of the evolutionary algorithm for the same case when the BOS scheme is repeated 25 times (run 6).  285 
The same pattern of convergence is seen as with the single run, and the small range of the median 286 
objective function values shows that the algorithm is statistically stable.  Note that Figure 7 shows the 287 
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objective values of the individuals, whereas Figure 8 shows the median objective values of various 288 
runs. 289 
Similar results are also seen in Figure 9 for the case of 100 individuals in 100 generations (run 290 
7).  Although there is a large range in the objective function values at each  generation, the median 291 
objective value reaches a constant value after around 20 iterations.  The objective value reaches a 292 
slightly smaller value than in Figure 7, showing that there is a small additional benefit in the larger 293 
population size.  However, the benefit is not large, and the use of 20 individuals in 20 generations is 294 
considered to be adequate for the purposes of providing good quality dose distributions. 295 
 296 
 297 
 298 
Table 3.  Impact of varying the parameters of the evolutionary algorithm in the prostate B case.  The 299 
pertinent changes in parameter values are shown in bold type.  Note that the median and range final objective 300 
values for run 6 relate to the median value attained by the population at each of multiple runs rather than the 301 
value attained by the individuals at a single run. 302 
 303 
PARAMETER RUN 1 RUN 2 RUN 3 RUN 4 RUN 5 RUN 6 RUN 7 
Population size (plans) 20 20 20 20 20 20 100 
Generations 20 20 20 20 20 20 100 
Statistical repeats 1 1 1 1 1 25 1 
Crossover ratio 0.4 0.3 0.5 0.4 0.4 0.4 0.4 
Mutation probability 0.05 0.05 0.05 0.01 0.1 0.05 0.05 
Final objective median 512 509 515 518 526 536 493 
Final objective range 466-664 483-659 461-568 482-594 489-849 512-555 432-945 
Lowest objective found 456 481 457 482 485 447 418 
 304 
 305 
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 306 
Figure 7.  Convergence of the objective function for the prostate B case with 15 beams selected from 110 307 
candidate beams.  The boxes represent the median and the 25
th
 and 75
th
 percentiles of the 20 individual objective 308 
function values at each generation.  The error bars represent the range of these 20 objective values.  The green 309 
dotted line shows the objective value for the preset short path and the blue dashed line shows the objective value 310 
for the body path. 311 
 312 
 313 
 314 
Figure 8.  Statistical performance of the evolutionary algorithm for the prostate B case.  The algorithm has been 315 
run 25 times and the median objective value of the population of 20 individuals recorded for each run.  The 316 
boxes represent the median and the 25
th
 and 75
th
 percentiles of the 25 median objective function values at each 317 
generation.  The error bars represent the range of these 25 median objective values.  The green dotted line shows 318 
the objective value for the preset short path and the blue dashed line shows the objective value for the body path. 319 
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 320 
 321 
Figure 9.  Convergence of the objective function for the prostate B case with 15 beams selected from 110 322 
candidate beams.  In this run, 100 individuals in 100 generations are used.  The boxes represent the median and 323 
the 25
th
 and 75
th
 percentiles of the 100 individual objective function values at each generation.  The error bars 324 
represent the range of these 100 objective values.  The green dotted line shows the objective value for the preset 325 
short path and the blue dashed line shows the objective value for the body path. 326 
 327 
 328 
 329 
 330 
The impact of the parameters used in the evolutionary algorithm on the median final objective 331 
value for the BOS result in the liver case is shown in Table 4.  As with the prostate B case, the 332 
standard run (run 1), is shown to produce final objective values which are competitive with the other 333 
runs.  The difference in magnitude of the objective function values, compared to the prostate B case, 334 
is a reflection of the different anatomical structures and importance factors used for the two cases, and 335 
comparison of these values between the cases is therefore not meaningful.  Figure 10 shows the 336 
objective values for 20 iterations of the BOS scheme for the liver case, corresponding to run 1 of 337 
Table 4.  The optimisation rapidly reaches convergence to a fit population of treatment plans.  The 338 
final objective value is better than that of the preset short path and approaching that of the body path.  339 
Figure 11 shows the results of the evolutionary algorithm for the same case when the BOS scheme is 340 
repeated 25 times (run 6).  Again, the small range of the median objective function values shows that 341 
the algorithm is statistically stable. 342 
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Table 4.  Impact of varying the parameters of the evolutionary algorithm in the liver case.  The 343 
pertinent changes in parameter values are shown in bold type.  Note that the median and range final objective 344 
values for run 6 relate to the median value attained by the population at each of multiple runs rather than the 345 
value attained by the individuals at a single run. 346 
 347 
PARAMETER RUN 1 RUN 2 RUN 3 RUN 4 RUN 5 RUN 6 
Population size (plans) 20 20 20 20 20 20 
Generations 20 20 20 20 20 20 
Statistical repeats 1 1 1 1 1 25 
Crossover ratio 0.4 0.3 0.5 0.4 0.4 0.4 
Mutation probability 0.05 0.05 0.05 0.01 0.1 0.05 
Final objective median 16.8 17.7 19.3 15.1 18.9 16.7 
Final objective range 12.9-28.3 14.6-28.2 14.0-25.8 13.1-18.0 14.7-27.1 13.3-18.8 
Lowest objective found 12.9 14.0 14.0 13.0 11.9 11.0 
 348 
 349 
 350 
 351 
 352 
Figure 10.  Convergence of the objective function for the liver case with 15 beams selected from 110 candidate 353 
beams.  The boxes represent the median and the 25
th
 and 75
th
 percentiles of the 20 individual objective function 354 
values at each generation.  The error bars represent the range of these 20 objective values.  The green dotted line 355 
shows the objective value for the preset short path and the blue dashed line shows the objective value for the 356 
body path. 357 
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 358 
Figure 11.  Statistical performance of the evolutionary algorithm for the liver case.  The algorithm has been run 359 
25 times and the median objective value of the population of 20 individuals recorded for each run.  The boxes 360 
represent the median and the 25
th
 and 75
th
 percentiles of the 25 median objective function values at each 361 
generation.  The error bars represent the range of these 25 median objective values.  The green dotted line shows 362 
the objective value for the preset short path and the blue dashed line shows the objective value for the body path. 363 
 364 
 365 
In terms of the clinical quality of the treatment plans, the clinical constraints are met in most 366 
cases where a solution is feasible.  There are several cases, notably prostate PTV overlapping the 367 
rectum, and lung PTV overlapping with the proximal bronchial tree, where a solution is infeasible for 368 
certain beam arrangements.  In addition, there are several other instances where the constraints are not 369 
met due to the PTV overlapping with a critical structure, which is difficult to handle due to the 370 
requirement in the computational framework to have only one structure defined at each location (see 371 
figure 1).  The PTV is always set to the highest priority, so it is difficult to control the dose in the 372 
regions where a critical structure overlaps with the PTV.  However, in general, clinical constraints are 373 
met in the cases presented. 374 
Dose-volume histograms comparing the body path, the preset short path and the BOS path are 375 
shown in Figure 12.  For the prostate A case, the PTV receives a similar dose with the body path, the 376 
preset short path and the BOS path.  The rectal dose passes the 18.12 Gy at 50% volume constraint 377 
with the full path and the BOS path but fails with the preset short path.  Meanwhile the bladder dose is 378 
lower with BOS than with the body path and the femoral head dose is higher than with the body path.  379 
However, these doses are within tolerance (principally 18.12 Gy at 50% for the bladder and 20 Gy 380 
maximum dose for the femoral heads) for all of the techniques. 381 
For the prostate B case, the PTV dose for the preset short path is similar to that for the body 382 
path, while the dose with BOS is slightly less, which in the context of this brachtherapy-like boost 383 
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protocol, represents a reduction in plan quality.  However, all techniques give PTV dose which meets 384 
the constraints (at least 38.00 Gy at 95%, at least 47.50 Gy at 50% and at least 57.00 Gy at 15%).  The 385 
urethra dose is similar with all techniques and within the tolerance of 39.90 Gy at 50%.  Rectum dose 386 
is slightly higher with BOS than with the body path or the preset short path, but again within tolerance 387 
(principally 28.50 Gy at 2 cm
3
) for all techniques. 388 
For the lung case, the plan with the preset short path is slightly lower in quality than the plan 389 
with the body path, and the plan with BOS is slightly lower in quality still, particularly in terms of 390 
proximal bronchus and oesophagus dose, but this is a very minor effect.  All dose constraints are met, 391 
except for the proximal bronchus (18.00 Gy at 4 cm
3
), which is not met by any of the three plans, due 392 
to overlap with the PTV. 393 
For the liver case, there is little difference dosimetrically between the three types of plan 394 
shown in the DVHs.  The PTVconstraints (principally 42.75 Gy at 95%) and the normal liver 395 
constraints (principally 15 Gy at 50%) are met by all plans.  Similarly, with the partial breast case, the 396 
techniques are dosimetrically very similar and meet the PTV constraint (35.00 Gy at 95%) and the 397 
constraint on the whole ipsilateral breast (17.50 Gy at 40%). 398 
 399 
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 400 
 401 
Figure 12.  Dose-volume histograms for (a) prostate A, (b) prostate B, (c) lung, (d) liver and (e) partial breast 402 
cases.  Dotted lines: body path (110 nodes), dashed lines: preset short path (36 nodes), solid lines: BOS path (15 403 
nodes).  The principal dose constraints are shown as points.  The PTV constraints in (b) are all minimum dose 404 
constraints. 405 
 406 
407 
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4.  Discussion 408 
These results show that our fast optimisation scheme is able to produce plans of a clinical 409 
standard for predefined beam arrangements such as the body path and the preset short path, within a 410 
very practical timeframe.  Both the treatment time and the treatment planning time can be reduced 411 
significantly by using a preset short path, as both are approximately proportional to the number of 412 
beams.  The benefit of this type of approach has been shown by a study of standardized beam 413 
bouquets for lung planning [36].  The treatment plans in that study contain around six coplanar beams, 414 
whereas 36 non-coplanar beams are used in the present study, but the similarity in outcome is clear: 415 
carefully chosen standardized beams can produce good quality treatment plans. 416 
However, the greatest benefit in treatment time is expected to be achieved with a BOS path.  417 
In this case, as few as 15 beams can be used for the treatment, with plan quality which is almost as 418 
high as with the 110-node body path.  The BOS path has the shortest treatment time, although as there 419 
are similar monitor units and number of apertures for the BOS path compared to the preset short path, 420 
the beam-on time and the aperture reshaping times are similar for both paths, and the reduction in 421 
treatment time with the BOS path is due to the reduction in robot traversal time.  The treatment 422 
planning time is much longer with this BOS algorithm, but there are a number of adjustments to the 423 
method which would enable it to be used in a much shorter time in a clinical environment, such as 424 
limiting the number of iterations for the optimisation at each fixed beam arrangement, and limiting the 425 
low-dose extent of the dij matrices.  Furthermore, it may be possible to use the information gained 426 
from this study to design better class solutions without requiring the BOS algorithm to be run for each 427 
patient in the clinical environment. 428 
The results of this study are similar to those of Rossi et al. [3] for Cyberknife treatment of 429 
prostate with a brachytherapy-like SABR protocol.  That study investigates candidate beam sets 430 
consisting of a full body path, a coplanar path and three extended body paths consisting of 180 – 500 431 
nodes.  Between 10 and 30 nodes are then selected from these node sets.  They find that selecting 432 
beams from the largest set of candidate directions favours plan quality.  In their study, increasing the 433 
number of selected beams from 10 to 30 has little effect on PTV coverage due to the design of the 434 
study, but gradually improves the mean dose to the bladder and the irradiated volume of urethra.  The 435 
impact of increasing the beam number levels off between 15 and 20 beams.  The mean dose to the 436 
rectum and the rectal irradiated volume also decrease with increasing number of beams, with most of 437 
the effect seen with beam numbers up to 20.  The finding of the present study that around 15 beams is 438 
sufficient to produce good quality plans is in accord with these results.  Rossi et al. [3] report 439 
optimisation times of up to 45 h, whereas the present work allows an optimisation time of an order of 440 
magnitude shorter. 441 
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Much of the experience with a C-arm linear accelerator can also be compared with the present 442 
study, such as the work of Woudstra et al. [4], Vaitheeswaran et al. [19], Breedveld et al. [8], Amit et 443 
al. [20] and Bangert and Unkelbach [23].  Most recently, Liu et al. [21] report on selecting eight 444 
beams from either 18 coplanar or 56 non-coplanar candidate orientations for prostate, head and neck, 445 
or liver.  They find that a sparse optimisation which approximates the exact BOS problem, thereby 446 
allowing the use of a gradient method, can provide good quality plans with improved computational 447 
efficiency. 448 
To produce such high-quality treatment plans, a series of annular structures around the PTV 449 
have been used in the present study.  These provide dose distributions evenly balanced around the 450 
area treated.  The biggest challenge in producing non-coplanar plans with few beams by orientation 451 
selection is to ensure that the surface dose is distributed around sufficiently.  It has been found that 15 452 
beams are sufficient for this, with 20 beams more than adequate.  However, there are some practical 453 
limitations to this study.  In particular, the method of sequencing the fluence profiles into deliverable 454 
segments [34] yields many small segments, with the effect that the total monitor units required are 455 
very high.  This effect could be overcome by using a more conformal segmentation algorithm.  456 
Moreover, no attempt has been made to optimize the monitor units as part of the objective function, 457 
but this should be possible.  Another limitation is that dose components have been calculated from a 458 
small field and the total dose due to a larger field has been calculated as a summation of these 459 
elemental doses.  It is well known that this is not a very accurate method of calculating the dose in a 460 
large field.  This could possibly be overcome by applying a segment weight optimisation in a post 461 
processing step. 462 
This study begins with candidate beam orientations chosen to avoid collisions.  This is similar 463 
to the work of Breedveld et al. [8] and Bangert et al. [25].  The present study uses an evolutionary 464 
algorithm to select beam orientations, with a fluence optimisation, segmentation and aperture 465 
optimisation for each plan at each iteration.  However, use of fluence optimisation and aperture 466 
optimisation at each iteration may ultimately not be necessary, as fluence optimisation alone may give 467 
the required result.  As the aperture optimisation problem is posed in this work as a special case of 468 
fluence optimisation, so that its speed of execution is approximately the same as the speed of fluence 469 
optimisation, removing the aperture optimisation would have the effect of reducing the optimisation 470 
time by approximately half.  This is also the approach taken by Rowbottom et al. [39] and Hou et al. 471 
[38].  Further work is needed to establish what simplifications of the inverse planning can be achieved 472 
for the same quality of plan. 473 
 474 
 475 
 476 
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5.  Conclusion 477 
The gradient descent method implemented in a multiple-core computation environment offers 478 
the possibility of fast optimisation for MLC-based delivery on the large number of nodes encountered 479 
in the Cyberknife system.  The number of delivery nodes can be reduced by using a preset short path, 480 
but the greatest time saving is achieved by beam orientation selection.  The beam selection method 481 
takes much longer to run than the standard optimisation method using a fixed set of nodes.  However, 482 
evolutionary computing produces results which are almost as good in quality as those using the body 483 
path.  The main advantage of the fewer nodes is expected to be a reduction in treatment time. 484 
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